SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Vascular and Endovascular Surgery
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Goffin, Y.A.
Right arrow Articles by Van Hoeck, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Goffin, Y.A.
Right arrow Articles by Van Hoeck, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Banking and Distribution of Large Cryopreserved Arterial Homografts in Brussels: Assessment of 4 Years of Activity by the European Homograft Bank (EHB) with Reference to Implantation Results in Reconstruction of Infected Infrarenal Arterial Prostheses and Mycotic Aneurysms

Y.A. Goffin

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

D. Grandmougin

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

G. Wozniak

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

V. Keppenne

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

A. Nevelsteen

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

P. Vogt

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

H. Van Damme

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

C. Stankowiak

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

F. Dapper

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

R. De Geest

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

Fr. Deuvaert

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

B. Van Hoeck

European Homograft Bank International Association c/o Military Hospital Rue Bruyn 1120 Brussels, Belgium

In 1991 European Homograft Bank (EHB) initiated a program of cryopreservation and distribution of large arteries to meet a new demand for quality-controlled arterial homo grafts of various sizes. From May 1991 to June 1995, 308 arteries have been registered from 136 donors: 122 brain death cases and 14 cadavers (mean age 34 years, male/female ratio 1.52/1); 263 arteries were cryopreserved (113 aortas, 64 aortic bifur cations, and 86 femoral); 19 were discarded for atherosclerosis (6.7%); 10 batches of arteries were partially or totally discarded because of persistent contamination and further eight batches for positive or doubtful viral serology. One hundred patients were treated in nine European centers with one (N = 69) or more EHB homografts. Indications were: infected prosthesis 70 (17 with aortoenteric fistula); mycotic aneurysm 19 (four ascending aortas, two with bronchial fistula); neoplastic infiltration of subrenal aorta one; extracardiac reconstructions/shunts 10. (continued on next page) (Abstract continued) Results from homograft reconstructions in infected prosthesis or mycotic aneurysm were available in 90 patients. There were 19 early deaths and 24 early complications, three were directly graft-related and included a fatal case of homograft rupture. Sixty- seven vascular cases were followed up from 1 month onward (mean: 16 months): 50 were uneventful; there were nine late deaths, of which two resulted from graft-related digestive hemorrhage; there were eight cases of late complications; three arteries were partly explanted as a result of focal thrombosis. Four patients were lost to follow-up. In the cases of aortoenteric fistula, however, the results were disappointing with only five late survivors of the 16 treated patients. Finally, these results show that cryopreserved arteries seem to perform as well in the midterm as the fresh ones.

Both the banking activity of cryopreserved homografts and the short- to mid-term performances of the implants in cases of prosthetic or native arterial infection are very satisfactory, provided no aortoenteric fistula is present. Cryopreserved arteries can also be used for extracardiac shunts and reconstructions.

Vascular and Endovascular Surgery, Vol. 32, No. 1, 19-32 (1998)
DOI: 10.1177/153857449803200104


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement